CD5 CAR T-Cells for Treatment of Patients with Relapsed/Refractory CD5 Expressing T-Cell Lymphoma Demonstrates Safety and Anti-Tumor Activity

被引：0
|
作者：
Hill, LaQuisa [1 ]
Rouce, Rayne Helen [1 ]
Smith, Tyler S. [1 ]
Yang, Lina [1 ]
Srinivasan, Madhuwanti [1 ]
Zhang, Huimin [1 ]
Perconti, Silvana [1 ]
Mehta, Birju [1 ]
Dakhova, Olga [1 ]
Randall, Josalind [1 ]
Grilley, Bambi [1 ]
Heslop, Helen E. [1 ]
Brenner, Malcolm K. [1 ]
Mamonkin, Maksim [1 ]
机构：
[1] Houston Methodist Hosp, Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
354
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [41] Clinical Development of Senza5™ CART5: a Novel Dual Population CD5 CRISPR-Cas9 Knocked out Anti-CD5 Chimeric Antigen Receptor T Cell Product for Relapsed and Refractory CD5+Nodal T-Cell Lymphomas
    Patel, Ruchi P.
    Ghilardi, Guido
    Porazzi, Patrizia
    Yang, Steven
    Qian, Dean
    Pajarillo, Raymone
    Wang, Michael
    Zhang, Yunlin
    Schuster, Stephen J.
    Barta, Stefan K.
    Nimmagadda, Aditya
    Snook, Adam
    Siciliano, Nicholas A.
    Ruella, Marco
    BLOOD, 2022, 140 : 1604 - 1605
  • [42] Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
    Jia Feng
    Haichan Xu
    Andrew Cinquina
    Zehua Wu
    Qi Chen
    Ping Zhang
    Xingen Wang
    Huiming Shan
    Lei Xu
    Qian Zhang
    Lihua Sun
    Wenli Zhang
    Kevin G. Pinz
    Masayuki Wada
    Xun Jiang
    William M Hanes
    Yupo Ma
    Hongyu Zhang
    Stem Cell Reviews and Reports, 2021, 17 : 652 - 661
  • [43] Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
    Feng, Jia
    Xu, Haichan
    Cinquina, Andrew
    Wu, Zehua
    Chen, Qi
    Zhang, Ping
    Wang, Xingen
    Shan, Huiming
    Xu, Lei
    Zhang, Qian
    Sun, Lihua
    Zhang, Wenli
    Pinz, Kevin G.
    Wada, Masayuki
    Jiang, Xun
    Hanes, William M.
    Ma, Yupo
    Zhang, Hongyu
    STEM CELL REVIEWS AND REPORTS, 2021, 17 (02) : 652 - 661
  • [44] Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells
    Feng, Jia
    Xu, Haichan
    Cinquina, Andrew
    Wu, Zehua
    Zhang, Wenli
    Sun, Lihua
    Chen, Qi
    Tian, Lei
    Song, Le
    Pinz, Kevin G.
    Wada, Masayuki
    Jiang, Xun
    Hanes, William M.
    Ma, Yupo
    Zhang, Hongyu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] THYROID-SPECIFIC CD8+ T-CELL LINE DERIVED FROM AUTOIMMUNE-THYROIDITIS LESIONS IN MICE DEPLETED OF CD5 BRIGHT T-CELLS
    SUGIHARA, S
    FUJIWARA, H
    SHEARER, GM
    FASEB JOURNAL, 1991, 5 (04): : A606 - A606
  • [46] Efficacy and side effects of anti-CD19 CAR T-cell therapy in patients with relapsed/refractory gastrointestinal lymphoma
    Jiang, Yi Li
    Mu, Juan
    Cui, Rui
    Li, Xin
    Wang, Jia
    Li, Qing
    Li, Jingyi
    Mou, Nan
    Deng, Qi
    CANCER MEDICINE, 2024, 13 (04):
  • [47] Unedited CD7 CAR T-Cells Overcome Fratricide and Produce Superior Anti-Tumor Activity in a Preclinical Model of T-Cell Leukemia
    Watanabe, Norihiro
    Mo, Feiyan
    Ma, Royce
    Srinivasan, Madhuwanti
    McKenna, Mary K.
    Scherer, Lauren D.
    Mamonkin, Maksim
    MOLECULAR THERAPY, 2021, 29 (04) : 302 - 303
  • [48] TREATMENT OF MURINE CD5 B-CELLS WITH ANTI-IG, BUT NOT LPS, INDUCES SURFACE CD5 - 2 B-CELL ACTIVATION PATHWAYS
    WORTIS, HH
    CONG, YZ
    RABIN, E
    FASEB JOURNAL, 1991, 5 (05): : A968 - A968
  • [49] PHORBOL ESTER ACTIVATES CD5(+) LEUKEMIC B-CELLS VIA A T-CELL INDEPENDENT MECHANISM
    TANGYE, SG
    WESTON, KM
    RAISON, RL
    IMMUNOLOGY AND CELL BIOLOGY, 1995, 73 (01): : 44 - 51
  • [50] SIMULTANEOUS LIGATION OF CD5 AND CD28 ON RESTING LYMPHOCYTES-T INDUCES T-CELL ACTIVATION IN THE ABSENCE OF T-CELL RECEPTOR/CD3 OCCUPANCY
    VERWILGHEN, J
    VANDENBERGHE, P
    WALLAYS, G
    DEBOER, M
    ANTHONY, N
    PANAYI, GS
    CEUPPENS, JL
    JOURNAL OF IMMUNOLOGY, 1993, 150 (03): : 835 - 846
12345